Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISCARD: Safe Discontinuation of Antidepressants
NCT07393919Phase 4Not yet recruiting
- Sponsor
- Università degli Studi di Verona
- Start
- Feb 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD), sponsored by Università degli Studi di Verona. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07393919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393919.